Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial
Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Conference item |
Julkaistu: |
American Society of Tropical Medicine and Hygiene
2018
|